Plasmagen Biosciences taps into the niche Indian biopharma market with the launch of CSL’s Haemocomplettan P Read more
Alembic Pharma announces U.S. FDA approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and tentative approval for Dabigatran Etexilate Capsules, 110 mg Read more
FOPE and PharmaState Academy sign MOU to enhance pharma workforce skillsets and capabilities Read more
Wanbury’s Patalganga manufacturing facility clears U.S. FDA inspection with zero observations Read more
FDA approved KEYTRUDA in combination with chemotherapy for adult patients with endometrial carcinoma Read more
U.S. FDA approves CAPVAXIVE (V116), specifically designed for pneumococcal disease in adults Read more
Alembic Pharma announces USFDA final approval for Icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe Read more
CALQUENCE plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial Read more